{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T21:59:42Z","timestamp":1771883982110,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Innere Medizin"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s00108-025-02051-8","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T10:57:25Z","timestamp":1768561045000},"page":"282-288","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Aspekte einer palliativen Pharmakotherapie bei geriatrischen Patienten: Was macht noch Sinn bei h\u00f6hergradiger Frailty?","Aspects of palliative pharmacotherapy in geriatric patients: what is rational in the presence of severe frailty?"],"prefix":"10.1007","volume":"67","author":[{"given":"Achim","family":"Rehlaender","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. V.","family":"Pfeiffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"2051_CR1","doi-asserted-by":"publisher","DOI":"10.17433\/978-3-17-031660-7","volume-title":"Umgang mit Multimorbidit\u00e4t und Multimedikation","author":"H Burkhardt","year":"2019","unstructured":"Burkhardt\u00a0H (2019) Umgang mit Multimorbidit\u00e4t und Multimedikation. Kohlhammer"},{"key":"2051_CR2","first-page":"105122","volume":"25","author":"E Hurley","year":"2024","unstructured":"Hurley\u00a0E, Dalton\u00a0K, Byrne\u00a0St, Foley\u00a0T, Walsh\u00a0E (2024) Pharmacist-led deprescribing using STOPPFrail for frail older adults in nursing homes. JAMDA 25:105122","journal-title":"JAMDA"},{"key":"2051_CR3","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/jgs.15616","volume":"67","author":"W Thompson","year":"2019","unstructured":"Thompson\u00a0W, Lunby\u00a0C, Graabaek\u00a0T, Nielsen\u00a0DS, Ryg\u00a0J, Sondergaard\u00a0J, Pottegard\u00a0A (2019) Tools for Deprescribing in Frail Older Persons and Those with Limited Life Expectancy: A\u00a0Systematic Review. JAGS 67:172\u2013180","journal-title":"JAGS"},{"issue":"12","key":"2051_CR4","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1007\/s00108-009-2518-4","volume":"50","author":"HK Berthold","year":"2009","unstructured":"Berthold\u00a0HK, Steinhagen-Thiessen\u00a0E (2009) Arzneimitteltherapie im Alter: Wo liegen die Probleme? Was soll man tun, was muss man lassen? Internist 50(12):1415\u20131424","journal-title":"Internist"},{"key":"2051_CR5","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.eurger.2015.07.008","volume":"6","author":"N Molist Brunet","year":"2015","unstructured":"Molist Brunet\u00a0N, Espaulella Panicot\u00a0J, Sevilla-Sanchez\u00a0D, Amblas Novellas\u00a0J, Codina\u00a0JC, Altimiras Roset\u00a0J, Gomez-Batiste\u00a0X (2015) A\u00a0patient-centered prescription model assessing appropriateness of chronic drug therapy in older patients at the end of life. Eur Geriatr Med 6:565\u2013569","journal-title":"Eur Geriatr Med"},{"key":"2051_CR6","doi-asserted-by":"publisher","first-page":"m1822","DOI":"10.1136\/bmj.m1822","volume":"369","author":"A Rieckert","year":"2020","unstructured":"Rieckert\u00a0A, Reeves\u00a0D, Altiner\u00a0A, Drewelow\u00a0E, Esmail\u00a0A, Flamm\u00a0M, Hann\u00a0M, Johansson\u00a0T, Klaassen-Mielke\u00a0R, Kunnamo\u00a0I, L\u00f6ffler\u00a0C, Piccoliori\u00a0G, Sommerauer\u00a0C, Trampisch\u00a0US, V\u00f6gele\u00a0A, Woodham\u00a0A, S\u00f6nnichsen\u00a0A (2020) Use of an electronic decision support tool to reduce polypharmacy in elderly people with chronic diseases: cluster randomize controlled trial. BMJ 369:m1822","journal-title":"BMJ"},{"issue":"18","key":"2051_CR7","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1001\/archinternmed.2010.355","volume":"170","author":"D Garfinkel","year":"2010","unstructured":"Garfinkel\u00a0D, Mangin\u00a0D (2010) Feasibility Study of a\u00a0Systematic Approach for Discontinuation of Multiple Medications in Older Adults. Arch Intern Med 170(18):1648\u20131654","journal-title":"Arch Intern Med"},{"key":"2051_CR8","first-page":"38","volume":"1","author":"DEGAM","year":"2021","unstructured":"DEGAM (2021) Haus\u00e4rztliche S3-Leitlinie Multimedikation: Empfehlungen zum Umgang mit Multimedikation bei erwachsenen und geriatrischen Patienten. AWMF-Registernummer 053-043. Tab 1:38","journal-title":"Tab"},{"key":"2051_CR9","doi-asserted-by":"crossref","first-page":"e000131","DOI":"10.1161\/HCQ.0000000000000131","volume":"17","author":"KE Di Palo","year":"2024","unstructured":"Di Palo\u00a0KE, Feder\u00a0S, Baggenstos\u00a0YT, Cornelio\u00a0CK, Forman\u00a0DE, Goyal\u00a0P, Kwak\u00a0MJ, McIlvennen\u00a0CK (2024) Palliative pharmacotherapy for cardiovascular disease. A\u00a0Scientific Statement From the American Heart Association. Circ Cardiovasc Qual Outcomes 17:e131","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2051_CR10","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/bmj.312.7023.71","volume":"312","author":"DL Sackett","year":"1996","unstructured":"Sackett\u00a0DL, Rosenberg\u00a0WM, Gray\u00a0JA, Haynes\u00a0RB, Richardson\u00a0WS (1996) Evidence based medicine: what it is and what it isn\u2019t. BMJ 312:71\u201372","journal-title":"BMJ"},{"key":"2051_CR11","unstructured":"Krones T Beziehungen zwischen Patienten und Behandlungs\u2011\/ Betreuungs-teams und gemeinsame Entscheidungsfindung. Praxisbuch Ethik in der Medizin 2021 2.\u00a0Aufl. MWV, S.\u00a079ff."},{"key":"2051_CR12","unstructured":"DEGAM (2021) Haus\u00e4rztliche S3-Leitlinie Multimedikation: Empfehlungen zum Umgang mit Multimedikation bei erwachsenen und geriatrischen Patienten. AWMF-Registernummer 053-043, S.\u00a0117"},{"key":"2051_CR13","unstructured":"DEGAM (2021) Haus\u00e4rztliche S3-Leitlinie Multimedikation: Empfehlungen zum Umgang mit Multimedikation bei erwachsenen und geriatrischen Patienten. AWMF-Registernummer 053-043, S.\u00a083. Weitere Details unter https:\/\/www.cofrail.com"},{"key":"2051_CR14","first-page":"20","volume":"2018","author":"G Neitzke","year":"2017","unstructured":"Neitzke\u00a0G (2017) Sinn als Kriterium der Entscheidungsfindung am Lebensende. Divi Jahrb 2018:20","journal-title":"Divi Jahrb"},{"key":"2051_CR15","unstructured":"(2010) https:\/\/der-arzneimittelbrief.com\/artikel\/2010\/ein-algorithmus-zum-kuerzen-langer-verordnungslisten-denn-weniger-ist-mehr"},{"key":"2051_CR16","doi-asserted-by":"crossref","unstructured":"Stegmann ME, Festen S, Brandenbarg D, Schuling J, van Leeuwen B, de Graeff P (2019) Berendsen AJ Using the Outcome Prioritization Tool (OPT) to assess the preferences of older patients in clinical decision-making: A\u00a0review. Maturitas: 49\u201352","DOI":"10.1016\/j.maturitas.2019.07.022"},{"key":"2051_CR17","doi-asserted-by":"crossref","unstructured":"Holmes HM Rational prescribing for patients with a\u00a0reduced life expectancy. Clin Pharmacol Ther 85:103\u2013107G","DOI":"10.1038\/clpt.2008.211"}],"container-title":["Die Innere Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-025-02051-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-025-02051-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-025-02051-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T21:02:56Z","timestamp":1771880576000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-025-02051-8"}},"subtitle":["\u201eShared decision-making\u201c als Grundlage f\u00fcr L\u00f6sungsans\u00e4tze","Shared decision-making as the basis for finding solutions"],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["2051"],"URL":"https:\/\/doi.org\/10.1007\/s00108-025-02051-8","relation":{},"ISSN":["2731-7080","2731-7099"],"issn-type":[{"value":"2731-7080","type":"print"},{"value":"2731-7099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"4 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"A.\u00a0Rehlaender und E.V.\u00a0Pfeiffer geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}